In the ceRNA network, we found that miRNA hsa-mir-107 and lncRNA WDFY3-AS2 are associated with survival time and have a close relationship with the development and clinical outcome of cancer: hsa-mir-107 is a biomarker that is linked with the development of human cancer (46), and WDFY3-AS2 is linked with the tumor regression of ovarian cancer (47). Here, WDFY3 is linked to ovarian carcinoma.